About Nick Papadopoulos
Form D filings for Cage Pharmaceuticals in 2024 list Nick Papadopoulos as director.
Nick Papadopoulos first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Nick Papadopoulos in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Nick Papadopoulos works with at each company, as listed on that company's latest Form D.
Cage Pharmaceuticals, Inc. · Form D, May 31, 2024